ASH 2022 Presentations Lentiviral-mediated Gene Therapy for Patients with Fanconi Anemia [Group A]: Updated Results from Global RP-L102 Clinical Trials (Click to download)POSTER: Lentiviral-mediated Gene Therapy for Patients with Fanconi Anemia [Group A]: Updated Results from Global RP-L102 Clinical Trials (Click to download)Lentiviral-mediated Gene Therapy for Adults and Children with Severe Pyruvate Kinase Deficiency: Results from an Ongoing Global Phase 1 Study (Click to download)POSTER: Lentiviral-mediated Gene Therapy for Adults and Children with Severe Pyruvate Kinase Deficiency: Results from an Ongoing Global Phase 1 Study (Click to download)Interim Results from an Ongoing Phase 1/2 Study of Lentiviral-mediated Ex-vivo Gene Therapy for Pediatric Patients with Severe Leukocyte Adhesion Deficiency-I(Click to download)POSTER: Interim Results from an Ongoing Phase 1/2 Study of Lentiviral-mediated Ex-vivo Gene Therapy for Pediatric Patients with Severe Leukocyte Adhesion Deficiency-I (Click to download) 2021 Presentations PKD ASH 2021 (click to download)LAD-I ASH 2021 (click to download)FA ASH 2021 (click to download)ASH Investor Analyst Event (click to download) 2020 Presentations PKD ASH 2020 (click to download)ASH 2020 LAD (click to download)FA ASH 2020 (click to download)ASH Investor Analyst Event (click to download) 2019 Presentations FA US Phase 1 Poster ASH 2019 (click to download)ASH Presentation Webcast ASH Corporate Dec (click to download)
